• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Nausea (1970); Pain (1994); Vomiting (2144); Injury (2348)
Event Date 05/25/2017
Event Type  Injury  
Manufacturer Narrative
The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Review of the device labeling notes the following: warnings and precautions: the physiological response of the patient to the presence of the orbera® system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, acute pancreatitis, spontaneous inflation, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Possible complications of the use of the orbera® system include: gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.Continuing nausea and vomiting.This could result from direct irritation of the lining of the stomach or as a result of the balloon blocking the outlet of the stomach.It is even theoretically possible that the balloon could prevent vomiting (not nausea or retching) by blocking the inlet to the stomach from the esophagus.Abdominal or back pain, either steady or cyclic.
 
Event Description
Reported event from journal article titled: "ischemic renal injury complicating intragastric balloon insertion", acg case reports journal reported an orbera patient experienced ischemic renal injury as a complication of intragastric balloon (igb) insertion for weight reduction.Patient had no immediate post-procedure complications except for few episodes of nausea and vomiting.On day 40 post-igb insertion, patient presented to the emergency department with a 2-day history of left-flank pain associated with nausea but no vomiting.Abdominal (computed tomography) ct with intravenous contrast showed a fully distended igb that directly compressed the left renal vein.The left kidney was enlarged (11.73 cm), with a wedge-shaped hypodense area in the renal cortex and peri-renal fat stranding.The patient underwent urgent upper endoscopy for igb removal.The gastric mucosa was intact and healthy.The patient responded well to treatment, with complete clinical and radiologic resolution after balloon removal.Urine cultures came back negative.Magnetic resonance imaging (mri) of the abdomen was done one week after balloon removal for interval follow-up.A previously noted left renal hypodense lesion resolved with no focal areas of decreased enhancement.Patient did not have an apparent cause of renal ischemia other than a significant compression of the renal vessels by the balloon as seen on imaging.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia
Manufacturer Contact
laura leboeuf
1120 s capitol of texas hwy
bldg 1, ste 300
austin, TX 78746
5122795100
MDR Report Key7718706
MDR Text Key114984686
Report Number3006722112-2018-00179
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeSA
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 04/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberB-50000
Device Catalogue NumberB-50000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2018
Initial Date FDA Received07/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ONDANSETRON
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age25 YR
Patient Weight93
-
-